​

Funding Round

Series B - PanOptica

Series B - PanOptica

Investment Firm

Overview

PanOptica is a biopharma company developing ophthalmic therapeutics for the treatment of eye diseases.

Announced Date

May 27, 2016

Closed on Date

May 20, 2016

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Third Rock Ventures

Third Rock Ventures

Third Rock Ventures is a early_stage_venture and late_stage_venture and post_ipo and seed firm.

Novo Ventures

Novo Ventures

Novo Ventures is a early_stage_venture and late_stage_venture firm.

Participant Investors

3

Investor Name
Participant InvestorNovo Ventures
Participant InvestorSV Health Investors
Participant InvestorThird Rock Ventures

Round Details and Background

PanOptica raised $23883195 on 2016-05-27 in Series B

PanOptica is a biopharma company developing ophthalmic therapeutics for the treatment of eye diseases.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 06, 2017
Series B - PanOptica
2-11.0M
Jan 07, 2016
Series B - PanOptica
1-undefined
May 27, 2016
Series B - PanOptica
3-23.9M
Jan 04, 2011
Series A - PanOptica
3-30.0M

Recent Activity

There is no recent news or activity for this profile.